戻る Agenda
Best Practices for Virtual Meetings with FDA!
Session Chair(s)
Khyati Roberts, RPH
Retired
Retired, United States
Meetings with FDA during development are key to inform product strategies and increase probability of success. Given the recent COVID-19 pandemic, everyone has adjusted to a new 'norm' - virtual meetings. Hear from FDA and industry experts on best practices for holding a virtual meetings.
Learning Objective : Identify the best practices for virtual PDUFA meetings; Describe how to change the way you prepare for virtual meetings.
Speaker(s)
Best Practices for Virtual Meetings: Industry Perspective
Todd Paporello, PHARMD, MBA
Sanofi, United States
Vice President, Global Head of Regulatory Affairs, Specialty Care
FDA Update and Best Practices for Virtual Meetings
Khushboo Sharma, MBA
Accumulus Synergy, United States
Chief Executive Officer
Best Practices for Meeting Requests and Briefing Packages
Lisa Yanoff, MD
FDA, United States
Deputy Director of the Office of Cardiology, Hematology, Endocrinology and Nephr